Overview

A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The treatment of symptomatic, uncomplicated malaria caused by P. falciparum in adults.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Azithromycin
Chloroquine
Chloroquine diphosphate